Trial Profile
Phase II study of daily administration of TS-1 plus lentinan (LNT) in advanced or recurrent gastric cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2013
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Lentinan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 07 Aug 2012 New trial record